Personalized medicine test improves diagnosis of prostate cancer
Genolife researchers report on a new test based on methods of personalized medicine and genomic medicine for the diagnosis of prostate cancer. In Mexico, approximately 2 in 10 men develop prostate cancer and approximately 5,500 succumb to the disease each year. The diagnosis of prostate cancer can be made through the blood test for prostate-specific…